Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ENSG00000298615 is a long non-coding RNA (lncRNA) transcript expressed from the sense strand within an intronic region of the MYLK3 gene. It is not known to encode a protein or act as a receptor, enzyme, transporter, or transcription factor. There are no documented aliases, functional roles, disease associations, or interacting drugs for this transcript in the current scientific literature. No information describes it as a therapeutic target or biomarker. ENSG00000298615 is not considered a therapeutic target such as a receptor, enzyme, transporter, or transcription factor. The gene lacks alias names, clinical relevance, and structure-function information. Because it's an lncRNA intronic to MYLK3 and not a classic drug target, it is not appropriate for structured therapeutic target profiling.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Novel transcript, sense intronic to MYLK3 (ENSG00000298615).